Dual-Target RT-LAMP Kit for Rapid SARS-CoV-2 Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for rapid, sensitive, and cost-effective diagnostic methods to differentiate between SARS-CoV-2 infection and other highly human-pathogenic Betacoronavirus group B/C infections, such as SARS-CoV and MERS-CoV, particularly in low-resource settings.
Innovation Solution
Development of optimized RT-LAMP primer sets targeting the N gene for SARS-CoV-2 and the RdRp gene for Betacoronavirus group B/C, enabling rapid differential diagnosis with high sensitivity and specificity, including detection of variants of concern.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If RT-LAMP assay is used for rapid detection, then detection speed is improved (within 30 min), but differentiation capability between SARS-CoV-2 and other Betacoronaviruses deteriorates
Solution Approach 1:
The detection system is segmented into two independent RT-LAMP assays: one targeting the N gene for SARS-CoV-2 detection and another targeting the RdRp gene for Betacoronavirus group B/C detection. Each assay uses specific primers designed to recognize unique genomic regions, allowing simultaneous rapid detection and differentiation of SARS-CoV-2 from other related coronaviruses within 30 minutes.
Solution Approach 2:
The RdRp gene target serves a dual function: it detects Betacoronavirus group B/C infections and provides a reference for differential diagnosis. By designing the primer set to target a conserved region in the RdRp gene across multiple coronavirus species, the assay achieves broad detection capability while maintaining specificity through the N gene target for SARS-CoV-2 identification.
2Loss of time
If RT-LAMP assay is used for rapid detection, then detection speed is improved (within 30 min), but infrastructure requirements worsen (still requires laboratory equipment)
Solution Approach 1:
The RT-LAMP assay replaces the complex thermal cycling mechanical system of PCR with an isothermal amplification system that maintains a constant temperature of 65°C. This substitution eliminates the need for sophisticated thermal cyclers, allowing the use of simpler heating devices while maintaining rapid detection capability within 30 minutes and reducing infrastructure complexity.
3Measurement precision
If RT-LAMP assay is used, then sensitivity is improved (detects 10 genome copies), but cost worsens (requires optimized primer sets and reagents)
Solution Approach 1:
The primer sets are optimized with specific parameters including annealing temperature (65°C), primer concentrations, and Mg2+ concentration to achieve high sensitivity detection of 10 genome copies. By carefully adjusting these parameters during development, the assay achieves superior sensitivity while using standard RT-LAMP reagents that can be manufactured at reasonable costs, balancing performance with ease of manufacture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The primer sets achieve rapid detection of SARS-CoV-2 with a limit of 10 genome copies per reaction in less than 15 minutes, offering superior sensitivity and specificity compared to existing methods, and allow differentiation from other Betacoronaviruses.
Implementation Method 1
The RT-LAMP assay uses a DNA polymerization enzyme with high strand-displacement activity and 6 primers, specifically designed to recognize 8 distinct regions on the target gene, to synthesize large amounts of target viral nucleic acids under a constant temperature (65°C)
Implementation Method 2
The RT-LAMP (reverse-transcription loop-mediated isothermal amplification) appears among the most promising assays
Implementation Method 3
turbidity, as the reaction produces large amounts of magnesium pyrophosphate (a white precipitate)
Implementation Method 4
fluorescence, using DNA intercaling dyes
Data Source
Figure 1
Figure 1
Figure 1
AI summary
The invention relates to reagents and methods for the rapid detection of the presence and/or absence of SARS-CoV-2 or other betacoronavirus group B/C nucleic acid in a sample and their use for the diagnosis of an infection or the detection of an environmental contamination by SARS-CoV-2 or other betacoronavirus group B/C.